Brief: India's Marksans Pharma Dec-Qtr Consol Profit Rises
12/02/2018 07:08
Feb 12 (Reuters) - Marksans Pharma Ltd MARK.NS :
* DEC QUARTER CONSOL PROFIT 174.6 MILLION RUPEES VERSUS
PROFIT
115.2 MILLION RUPEES YEAR AGO
* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 2.18 BILLION
RUPEES
VERSUS 2.15 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE4S7mM6
Further company coverage: MARK.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg